These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38486418)

  • 1. Loss of psoas muscle during neoadjuvant treatment for rectal cancer is associated with poor oncological and surgical outcomes.
    Yassaie S; Lan R; Hodder R
    ANZ J Surg; 2024 Jun; 94(6):1146-1150. PubMed ID: 38486418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Sarcopenia on Treatment Outcomes and Toxicity in Locally Advanced Rectal Cancer.
    Curcean S; Gherman A; Tipcu A; Fekete Z; Muntean AS; Curcean A; Craciun R; Stanciu S; Irimie A
    Medicina (Kaunas); 2024 Oct; 60(10):. PubMed ID: 39459393
    [No Abstract]   [Full Text] [Related]  

  • 3. Sarcopenia assessed by skeletal muscle mass volume is a prognostic factor for oncological outcomes of rectal cancer patients undergoing neoadjuvant chemoradiotherapy followed by surgery.
    Horie K; Matsuda T; Yamashita K; Hasegawa H; Utsumi M; Urakawa N; Kanaji S; Oshikiri T; Kakeji Y
    Eur J Surg Oncol; 2022 Apr; 48(4):850-856. PubMed ID: 34756762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Sarcopenia Predict Local Response Rates After Chemoradiotherapy for Locally Advanced Rectal Cancer?
    Bedrikovetski S; Traeger L; Vather R; Sammour T; Moore JW
    Dis Colon Rectum; 2023 Jul; 66(7):965-972. PubMed ID: 36538702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quick and simple; psoas density measurement is an independent predictor of anastomotic leak and other complications after colorectal resection.
    Herrod PJJ; Boyd-Carson H; Doleman B; Trotter J; Schlichtemeier S; Sathanapally G; Somerville J; Williams JP; Lund JN
    Tech Coloproctol; 2019 Feb; 23(2):129-134. PubMed ID: 30790102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of measurement of skeletal muscle mass on clinical outcomes in patients with esophageal cancer undergoing esophagectomy after neoadjuvant chemotherapy.
    Ishida T; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Motoori M; Kimura Y; Nakajima K; Mori M; Doki Y
    Surgery; 2019 Dec; 166(6):1041-1047. PubMed ID: 31607486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is radiological psoas muscle area measurement a predictor of postoperative complications after rectal resection for rectal cancer? A retrospective study.
    Uehara H; Yamazaki T; Iwaya A; Kameyama H; Utsumi S; Harada R; Komatsu M; Hirai M; Kubota A; Katada T; Kobayashi K; Sato D; Yokoyama N; Kuwabara S; Otani T
    Surg Today; 2022 Feb; 52(2):306-315. PubMed ID: 34309711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased total psoas muscle area after neoadjuvant therapy is a predictor of increased mortality in patients undergoing oesophageal cancer resection.
    Yassaie SS; Keane C; French SJH; Al-Herz FAJ; Young MK; Gordon AC
    ANZ J Surg; 2019 May; 89(5):515-519. PubMed ID: 30959566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient's Skeletal Muscle Radiation Attenuation and Sarcopenic Obesity are Associated with Postoperative Morbidity after Neoadjuvant Chemoradiation and Resection for Rectal Cancer.
    Berkel AEM; Klaase JM; de Graaff F; Brusse-Keizer MGJ; Bongers BC; van Meeteren NLU
    Dig Surg; 2019; 36(5):376-383. PubMed ID: 29898443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of neoadjuvant treatment strategy on perioperative outcomes in locally advanced rectal cancer.
    McFeetors C; O'Connell LV; Choy M; Dundon N; Regan M; Joyce M; Meshkat B; Hogan A; Nugent E
    Colorectal Dis; 2024 Apr; 26(4):684-691. PubMed ID: 38424706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited Role for Routine Restaging After Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
    Caturegli I; Molin MD; Laird C; Molitoris JK; Bafford AC
    J Surg Res; 2020 Dec; 256():317-327. PubMed ID: 32712447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemoradiotherapy for rectal carcinoma: effects on anastomotic leak rate and postoperative bladder dysfunction after non-emergency sphincter-preserving anterior rectal resection. Results of the Quality Assurance in Rectal Cancer Surgery multicenter observational trial.
    Garlipp B; Ptok H; Schmidt U; Meyer F; Gastinger I; Lippert H
    Langenbecks Arch Surg; 2010 Nov; 395(8):1031-8. PubMed ID: 20711786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete response after neoadjuvant therapy in rectal cancer: to operate or not to operate?
    Dedemadi G; Wexner SD
    Dig Dis; 2012; 30 Suppl 2():109-17. PubMed ID: 23207942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcopenia, as Assessed by Psoas Cross-Sectional Area, Is Predictive of Adverse Postoperative Outcomes in Patients Undergoing Colorectal Cancer Surgery.
    Richards SJG; Senadeera SC; Frizelle FA
    Dis Colon Rectum; 2020 Jun; 63(6):807-815. PubMed ID: 32149784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 16. Can sarcopenia predict complete response after total neoadjuvant therapy in advanced rectal cancer? A multicentre observational cohort study.
    Bedrikovetski S; Traeger L; Price TJ; Carruthers S; Selva-Nayagam S; Moore JW; Sammour T
    J Surg Oncol; 2023 Jul; 128(1):75-84. PubMed ID: 36971689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Oncological Outcomes Following Anastomotic Leak in Rectal Cancer Surgery.
    Crippa J; Duchalais E; Machairas N; Merchea A; Kelley SR; Larson DW
    Dis Colon Rectum; 2020 Jun; 63(6):769-777. PubMed ID: 32109914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative sarcopenia is a poor prognostic factor in lower rectal cancer patients undergoing neoadjuvant chemoradiotherapy: a retrospective study.
    Abe S; Kawai K; Nozawa H; Sasaki K; Murono K; Emoto S; Kishikawa J; Ishii H; Yokoyama Y; Nagai Y; Anzai H; Sonoda H; Oba K; Ishihara S
    Int J Clin Oncol; 2022 Jan; 27(1):141-153. PubMed ID: 34741193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical features and prognosis of anastomotic leak after anterior resection for rectal cancer following neoadjuvant chemoradiotherapy].
    Qin QY; Wu YL; Cai YH; Kuang YY; He YJ; Huang XY; Wang H; Ma TH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Jun; 24(6):513-522. PubMed ID: 34148316
    [No Abstract]   [Full Text] [Related]  

  • 20. Value of combined multiparametric MRI and FDG-PET/CT to identify well-responding rectal cancer patients before the start of neoadjuvant chemoradiation.
    Schurink NW; Min LA; Berbee M; van Elmpt W; van Griethuysen JJM; Bakers FCH; Roberti S; van Kranen SR; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ
    Eur Radiol; 2020 May; 30(5):2945-2954. PubMed ID: 32034488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.